Patents by Inventor Prasad Jallepalli

Prasad Jallepalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Securin is required for chromosomal stability in human cells
    Patent number: 7354703
    Abstract: Securin-deficient cells and their isogenic securin-proficient counterparts are useful for screening potential anti-tumor agents. Potential therapeutic agents are screened for the ability to preferentially inhibit or kill a securin-deficient cell. The association of securin deficiency and chromosomal instability leading to aneuploidy, renders securin an excellent target for chemotherapeutic drug development.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: April 8, 2008
    Assignee: The Johns Hopkins University
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Prasad Jallepalli, Christoph Lengauer
  • Securin is required for chromosomal stability in human cells
    Publication number: 20020137018
    Abstract: Securin-deficient cells and their isogenic securin-proficient counterparts are useful for screening potential anti-tumor agents. Potential therapeutic agents are screened for the ability to preferentially inhibit or kill a securin-deficient cell. The association of securin deficiency and chromosomal instability leading to aneuploidy, renders securin an excellent target for chemotherapeutic drug development.
    Type: Application
    Filed: March 23, 2001
    Publication date: September 26, 2002
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Prasad Jallepalli, Christoph Lengauer